These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 20416103)
1. Cell-associated hemolysis activity in the clinical strain of Pseudomonas fluorescens MFN1032. Sperandio D; Rossignol G; Guerillon J; Connil N; Orange N; Feuilloley MG; Merieau A BMC Microbiol; 2010 Apr; 10():124. PubMed ID: 20416103 [TBL] [Abstract][Full Text] [Related]
2. Virulence of the Pseudomonas fluorescens clinical strain MFN1032 towards Dictyostelium discoideum and macrophages in relation with type III secretion system. Sperandio D; Decoin V; Latour X; Mijouin L; Hillion M; Feuilloley MG; Orange N; Merieau A BMC Microbiol; 2012 Sep; 12():223. PubMed ID: 23020706 [TBL] [Abstract][Full Text] [Related]
3. Involvement of a phospholipase C in the hemolytic activity of a clinical strain of Pseudomonas fluorescens. Rossignol G; Merieau A; Guerillon J; Veron W; Lesouhaitier O; Feuilloley MG; Orange N BMC Microbiol; 2008 Oct; 8():189. PubMed ID: 18973676 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic variation in the Pseudomonas fluorescens clinical strain MFN1032. Rossignol G; Sperandio D; Guerillon J; Duclairoir Poc C; Soum-Soutera E; Orange N; Feuilloley MG; Merieau A Res Microbiol; 2009 Jun; 160(5):337-44. PubMed ID: 19409488 [TBL] [Abstract][Full Text] [Related]
5. The clinical Pseudomonas fluorescens MFN1032 strain exerts a cytotoxic effect on epithelial intestinal cells and induces Interleukin-8 via the AP-1 signaling pathway. Madi A; Lakhdari O; Blottière HM; Guyard-Nicodème M; Le Roux K; Groboillot A; Svinareff P; Doré J; Orange N; Feuilloley MG; Connil N BMC Microbiol; 2010 Aug; 10():215. PubMed ID: 20698984 [TBL] [Abstract][Full Text] [Related]
6. Boolean models of biosurfactants production in Pseudomonas fluorescens. Richard A; Rossignol G; Comet JP; Bernot G; Guespin-Michel J; Merieau A PLoS One; 2012; 7(1):e24651. PubMed ID: 22303435 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the copper-responsive CopRSCD of a pathogenic Pseudomonas fluorescens strain. Hu YH; Wang HL; Zhang M; Sun L J Microbiol; 2009 Jun; 47(3):277-86. PubMed ID: 19557345 [TBL] [Abstract][Full Text] [Related]
9. The pathogenic potential of Pseudomonas fluorescens MFN1032 on enterocytes can be modulated by serotonin, substance P and epinephrine. Biaggini K; Barbey C; Borrel V; Feuilloley M; Déchelotte P; Connil N Arch Microbiol; 2015 Oct; 197(8):983-90. PubMed ID: 26175088 [TBL] [Abstract][Full Text] [Related]
10. Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putida. Mazurier S; Merieau A; Bergeau D; Decoin V; Sperandio D; Crépin A; Barbey C; Jeannot K; Vicré-Gibouin M; Plésiat P; Lemanceau P; Latour X Appl Environ Microbiol; 2015 Apr; 81(7):2579-90. PubMed ID: 25636837 [TBL] [Abstract][Full Text] [Related]
11. The two-component regulators GacS and GacA influence accumulation of the stationary-phase sigma factor sigmaS and the stress response in Pseudomonas fluorescens Pf-5. Whistler CA; Corbell NA; Sarniguet A; Ream W; Loper JE J Bacteriol; 1998 Dec; 180(24):6635-41. PubMed ID: 9852008 [TBL] [Abstract][Full Text] [Related]
12. A Pseudomonas fluorescens type 6 secretion system is related to mucoidy, motility and bacterial competition. Decoin V; Gallique M; Barbey C; Le Mauff F; Poc CD; Feuilloley MG; Orange N; Merieau A BMC Microbiol; 2015 Mar; 15():72. PubMed ID: 25886496 [TBL] [Abstract][Full Text] [Related]
13. Construction of an attenuated Pseudomonas fluorescens strain and evaluation of its potential as a cross-protective vaccine. Wang HR; Hu YH; Zhang WW; Sun L Vaccine; 2009 Jun; 27(30):4047-55. PubMed ID: 19501788 [TBL] [Abstract][Full Text] [Related]
14. Global control in Pseudomonas fluorescens mediating antibiotic synthesis and suppression of black root rot of tobacco. Laville J; Voisard C; Keel C; Maurhofer M; Défago G; Haas D Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1562-6. PubMed ID: 1311842 [TBL] [Abstract][Full Text] [Related]
15. Global GacA-steered control of cyanide and exoprotease production in Pseudomonas fluorescens involves specific ribosome binding sites. Blumer C; Heeb S; Pessi G; Haas D Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14073-8. PubMed ID: 10570200 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the aprX-lipA operon of Pseudomonas fluorescens B52: differential regulation of the proximal and distal genes, encoding protease and lipase, by ompR-envZ. McCarthy CN; Woods RG; Beacham IR FEMS Microbiol Lett; 2004 Dec; 241(2):243-8. PubMed ID: 15598539 [TBL] [Abstract][Full Text] [Related]
17. Multicopy suppression of a gacA mutation by the infC operon in Pseudomonas fluorescens CHA0: competition with the global translational regulator RsmA. Blumer C; Haas D FEMS Microbiol Lett; 2000 Jun; 187(1):53-8. PubMed ID: 10828400 [TBL] [Abstract][Full Text] [Related]
18. Response to Gaseous NO2 Air Pollutant of P. fluorescens Airborne Strain MFAF76a and Clinical Strain MFN1032. Kondakova T; Catovic C; Barreau M; Nusser M; Brenner-Weiss G; Chevalier S; Dionnet F; Orange N; Poc CD Front Microbiol; 2016; 7():379. PubMed ID: 27065229 [TBL] [Abstract][Full Text] [Related]
19. RsmY, a small regulatory RNA, is required in concert with RsmZ for GacA-dependent expression of biocontrol traits in Pseudomonas fluorescens CHA0. Valverde C; Heeb S; Keel C; Haas D Mol Microbiol; 2003 Nov; 50(4):1361-79. PubMed ID: 14622422 [TBL] [Abstract][Full Text] [Related]
20. Molecular typing of industrial strains of Pseudomonas spp. isolated from milk and genetical and biochemical characterization of an extracellular protease produced by one of them. Dufour D; Nicodème M; Perrin C; Driou A; Brusseaux E; Humbert G; Gaillard JL; Dary A Int J Food Microbiol; 2008 Jul; 125(2):188-96. PubMed ID: 18511140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]